Breaking News Instant updates and real-time market news.

BAC

Bank of America

$28.99

-0.23 (-0.79%)

, ABT

Abbott

$83.11

-0.69 (-0.82%)

20:25
07/16/19
07/16
20:25
07/16/19
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Bank of America (BAC), consensus 71c... Abbott Laboratories (ABT), consensus 80c... U.S. Bancorp (USB), consensus $1.07... PNC Financial (PNC), consensus $2.82... Progressive (PGR), consensus $1.43... Bank of New York Mellon (BK), consensus 95c... Omnicom Group (OMC), consensus $1.61... Textron (TXT), consensus 86c... Comerica (CMA), consensus $2.

BAC

Bank of America

$28.99

-0.23 (-0.79%)

ABT

Abbott

$83.11

-0.69 (-0.82%)

USB

U.S. Bancorp

$53.04

-0.07 (-0.13%)

PNC

PNC Financial

$138.66

-1.52 (-1.08%)

PGR

Progressive

$84.11

0.105 (0.12%)

BK

BNY Mellon

$43.13

-0.02 (-0.05%)

OMC

Omnicom

$84.08

0.065 (0.08%)

TXT

Textron

$54.02

0.59 (1.10%)

CMA

Comerica

$71.75

0.39 (0.55%)

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 26

    Aug

  • 06

    Sep

  • 16

    Oct

BAC Bank of America
$28.99

-0.23 (-0.79%)

06/18/19
06/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bank of America (BAC) upgraded to Outperform from Market Perform at BMO Capital with analyst James Fotheringham expecting upward consensus estimates revisions and a "multiple re-rating" to drive 34% total return in the shares. 2. SunPower (SPWR), SunRun (RUN) upgraded to Buy from Neutral as SolarEdge (SEDG) upgraded to Neutral from Sell at Goldman Sachs with analyst Brian Lee anticipating "volume tailwinds" in the second half of 2019 given the recent signs of strength in the sector's financing environment. 3. CNH Industrial (CNHI) upgraded to Hold from Sell at Deutsche Bank with analyst Chad Dillard saying he's turning positive on North America large agriculture. 4. U.S. Cellular (USM), Telephone and Data (TDS) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simon Flannery stating that he sees both stocks as "very attractively valued" with each down over 20% from their recent peak levels. 5. Prosperity Bancshares (PB) upgraded to Market Perform from Underperform at Raymond James with analyst Michael Rose saying the LegacyTexas Financial (LTXB) transaction provides meaningful scale in some of the most attractive markets in the country. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/17/19
BMOC
06/17/19
UPGRADE
Target $37
BMOC
Outperform
BMO upgrades Bank of America to Outperform, sees 34% return potential
BMO Capital analyst James Fotheringham upgraded Bank of America to Outperform from Market Perform with an unchanged price target of $37. The stock closed Monday down 11c to $27.93. The analyst expects upward consensus estimates revisions and a "multiple re-rating" to drive 34% total return in the shares. Bank of America's current valuation multiple is 15% below its long-term average, Fotheringham tells investors in a research note. Further, even if the Federal Reserve cuts rates, positive earnings revisions from better fees, tax rates, provisions and buybacks should "more than offset" any related net interest margin dilution, contends the analyst.
06/17/19
BMOC
06/17/19
UPGRADE
BMOC
Outperform
Bank of America upgraded to Outperform from Market Perform at BMO Capital
06/28/19
WELS
06/28/19
NO CHANGE
WELS
Market Perform
Impacts of Bank of America decision manageable for First Data, says Wells Fargo
Wells Fargo analyst Timothy Willi sees three potential outcomes as Bank of America (BAC) reportedly weighs the exit of its joint venture with First Data (FDC). The joint venture can be dissolved, the terms can be renegotiated more favorably for Bank of America, and/or Bank of America can acquire an increased ownership of the venture, Willi tells investors in a research note. The current agreement ends in June 2020 and any party wishing to terminate must give one year notice, the analyst adds. While he believes that each of these scenarios could be an incremental negative for First Data, the analyst thinks the impacts are either "manageable or immaterial" in the context of a combined Fiserv (FISV), First Data. Willi has a Market Perform rating on First Data.
ABT Abbott
$83.11

-0.69 (-0.82%)

04/29/19
PIPR
04/29/19
NO CHANGE
Target $165
PIPR
Overweight
Piper reiterates Overweight on DexCom after 'robust' teen survey results
There were 8,042 responses to Piper Jaffray's teen survey in February and March, of which 1,707 have diabetes or a member of their household does, analyst JP McKim tells investors in a research note. The survey implies underlying continuous glucose monitoring market growth of close to 58%, says the analyst. Abbott (ABT) reported 70% Libre growth in Q1 and DexCom (DXCM) reports May 1, McKim points out. He expects "continued strong growth" from DexCom following the "robust" survey results and reiterates an Overweight rating on the shares with a $165 price target.
04/18/19
LSCM
04/18/19
NO CHANGE
Target $100
LSCM
Buy
Investors should buy into Tandem Diabetes 'fire sale,' says Lake Street
Lake Street analyst Brooks O'Neil attributes the recent selloff in shares of Tandem Diabetes (TNDM) to investor fears related to the potential implications of "Medicare For All." Yesterday, the decline also appeared to "draw fuel from the strong growth" Abbott (ABT) reported for its Libre glucose monitor for diabetics, O'Neil tells investors in a research note titled "Fire Sale. Should You Buy? Yes. There Is No Fire. Affirm BUY, $100 PT." The analyst doubts the healthcare system will be changed significantly and on Libre, he says, "We're sorry, but we believe investors are either badly confused or just plain wrong." Abbott offers a low-cost version of the monitoring system but does not compete in any way with Tandem in its pump market, says the analyst. Rather, O'Neil thinks there are "potentially significant positives" for Tandem Diabetes related to the "enormous success" of Abbott's Libre franchise. The analyst sees an "extraordinarily positive" outlook for Tandem Diabetes and recommends buying the shares on the recent pullback. He affirms a Buy rating on the shares with a $100 price target.
04/03/19
JPMS
04/03/19
NO CHANGE
Target $175
JPMS
Overweight
JPMorgan remains 'very bullish' on DexCom despite Libre 2.0 uncertainty
The latest DexCom (DXCM) controversy is "whirling speculation" around Abbott's (ABT) Libre 2.0 launch, JPMorgan analyst Robbie Marcus tells investors in a research note. The analyst keeps an Overweight rating on DexCom shares with a $175 price target but expects uncertainty over Libre 2.0 to remain an overhang until it receives U.S. approval. However, he remains "very bullish" on the shares and sees "significant upside" to 2019 estimates. DexComis the best positioned in diabetes longer-term, Marcus contends.
04/15/19
RBCM
04/15/19
NO CHANGE
Target $82
RBCM
Sector Perform
Abbott price target raised to $82 from $77 at RBC Capital
RBC Capital analyst Brandon Henry raised his price target on Abbott to $82 ahead of its Q1 results, saying the "pattern of revenue growth" seen last year should continue this quarter as Core Laboratory, Electrophysiology, Structural Heart, and Diabetes Care product categories "lead the way." The analyst also expects Abbott's organic revenue growth in the Medical Devices segment to come at the high end of guidance, adding that while his new price target implies a multiple of 22.5-times vs. peer group's 21-times, he believes that the company's growth profile justifies the valuation premium. Henry recommends that investors buy the stock on "any weakness".
USB U.S. Bancorp
$53.04

-0.07 (-0.13%)

01/28/19
01/28/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Autohome (ATHM) downgraded to Underweight from Neutral at JPMorgan with analyst Binbin Ding saying he expects the company to see weakened pricing power amid a "challenging" market environment. 2. Vale (VALE) downgraded to Hold from Buy at HSBC and Jefferies, to Neutral from Outperform at Macquarie, and to Market Perform from Outperform at BMO Capital. 3. Amgen (AMGN) downgraded to In Line from Outperform at Evercore ISI with analyst Umer Raffat citing increased biosimilar competition and an imminent court decision on Enbrel patents with Sandoz. 4. Dynagas LNG (DLNG) downgraded to Neutral from Buy at B. Riley FBR with analyst Liam Burke saying the company "significantly" reduced its cash distribution in order to strengthen its balance sheet. 5. SunTrust (STI) and U.S. Bancorp (USB) were downgraded to Neutral from Outperform at Baird. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/08/19
02/08/19
NO CHANGE

Odeon's Bove says buy SunTrust, Midwest banks after deal announcement
Odeon analyst Dick Bove recommends investors buy shares of SunTrust (STI) following the company's announcement of an agreement to merge with BB&T (BBT), stating that the deal is expected to be accretive by 2021, but likely to be dilutive before this time. He also thinks investors should consider buying a group of Midwestern banks, as the deal puts "significant pressure" on those banks to merge. Banks such as Fifth Third (FITB) and KeyCorp (KEY) "need to join forces," while PNC (PNC) and U.S. Bancorp (USB) "need to buy more scale," Bove stated in his research note.
03/25/19
JEFF
03/25/19
NO CHANGE
JEFF
Jefferies downgrades Financials to Underweight on 'shocking' Fed meeting
Jefferies analyst Steven DeSanctis is "very surprised" by last week's Federal Reserve's decision taking rate hikes completely off table in 2019. The "shocking" Fed meeting means lower rates for longer, which is not good for Financials, DeSanctis tells investors in a research note. A "lack of catalysts and weaker earnings growth" going forward for the entire sector, not just banks, means an Underweight rating on the space makes sense, says the analyst. As such, he downgraded his rating on the Financial sector to Underweight from Market Weight. Publicly traded companies in the space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
06/28/19
WEDB
06/28/19
NO CHANGE
WEDB
M&T Bank total capital return plan below forecast, says Wedbush
Even though banks between $100B-$250B in assets are not subject to the Fed's formal stress test again until 2020, all of the banks in that asset range that Wedbush analyst David Chiaverini covers released capital plans for the next four quarters, he noted. All of the regional banks he covers plans for less in total capital returns via share buyback and dividends under their new capital plans than in their 2018 capital plans, except for an increase at Citizens Financial (CFG) and and no change at U.S. Bancorp (USB), the analyst pointed out. M&T Bank's (MTB) total capital plan of $1.9B was below last cycle and "well below" his forecast of $2.62B, Chiaverini added.
PNC PNC Financial
$138.66

-1.52 (-1.08%)

03/06/19
MACQ
03/06/19
UPGRADE
MACQ
Outperform
PNC Financial upgraded to Outperform from Neutral at Macquarie
Macquarie analyst David Konrad upgraded PNC Financial to Outperform from Neutral and raised his price target to $144 from $134 given recent multiple compression, high BlackRock estimates and potential regulatory change for capital deductions. Konrad said PNC's strong fee income growth remains a key differentiator and expects operating leverage benefits as the company lags peers in terms of their efficiency ratio.
06/14/19
RAJA
06/14/19
NO CHANGE
RAJA
State Street, BofA, PNC among likely CCAR 'winners,' says Raymond James
Ahead of the Fed's release of its annual Comprehensive Capital Analysis Review, or CCAR, on June 27, Raymond James analysts led by David Long previewed the event, noting that "less complex" firms with $100B-$250B in assets have been effectively removed from this year after the central bank moved them to a two-year stress test cycle. Of the 18 total bank holding companies reviewed, and the seven of which the firm covers, Long and the team see State Street (STT), Bank of America (BAC) and PNC Financial (PNC) as "likely winners," they noted.
03/06/19
03/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Kohl's (KSS) upgraded to Neutral from Underweight at Atlantic Equities. 2. Volaris (VLRS) double upgraded to Buy from Sell at Goldman Sachs. 3. Mylan (MYL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying he believes the stock "can finally outperform" for the remainder of 2019 following a substantial reset that has the shares trading near the bottom end of their historical range of the past five years and at a historical discount to peers. 4. PNC Financial (PNC) upgraded to Outperform from Neutral at Macquarie with analyst David Konrad citing recent multiple compression, high BlackRock estimates and potential regulatory change for capital deductions. 5. Ambarella (AMBA) upgraded to Buy from Hold at Craig-Hallum with analyst Richard Shannon saying he sees sales inflection coming in the second half, and as multiple indicators suggest growth in auto and security, supported by computer vision-enabled products. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PGR Progressive
$84.11

0.105 (0.12%)

06/28/19
WBLR
06/28/19
NO CHANGE
WBLR
Outperform
Progressive shares have 'plenty of upside left,' says William Blair
William Blair analyst Adam Klauber says his proprietary analysis indicates that Progressive's secular growth profile has improved due to accessing a larger total addressable market. The company's addressable market should more than triple to $413B by 2023 due to expansion into the newer markets of homeowners' and bundled auto, Klauber tells investors in a research note. He believes Progressive's market share should move from 2% in both markets today to at least the 5% to 6% range by 2023. Further, the company's earnings per share have moved from around the $2.00 level several years ago to potentially $6.50 in 2020, "which suggests there is plenty of upside left in the stock," says Klauber. He keeps an Outperform rating on Progressive.
06/13/19
RILY
06/13/19
NO CHANGE
Target $96
RILY
Buy
Progressive price target raised to $96 from $89 at B. Riley FBR
B. Riley FBR analyst Randy Binner raised his price target for Progressive to $96 from $89 and reiterates a Buy rating on the shares following the company's May operating results.
01/09/19
LEHM
01/09/19
NO CHANGE
LEHM
Barclays upgrades three P&C Insurers, downgrades RenaissanceRe
Barclays analyst Jay Gelb upgraded Travelers (TRV), Arch Capital Group (ACGL) and Progressive (PGR) to Overweight while downgrading RenaissanceRe to Underweight from Equal Weight. Travelers, Arch and Progressive are among the best managed companies in the Property and Casualty Insurance sector with "sustainably robust earning power, strong balance sheets, and increasingly attractive valuations," Gelb tells investors in a research note. He believes the recent share pullbacks have provided an attractive opportunity. And although he also views RenaissanceRe as well managed company, he thinks the stock's valuation is full and that reinsurance market conditions are unlikely to tighten.
03/07/19
FBCO
03/07/19
NO CHANGE
Target $80
FBCO
Outperform
Progressive price target raised to $80 from $73 at Credit Suisse
Credit Suisse analyst Michael Zaremski raised his price target for Progressive to $80 from $73 given his view that the company's underwriting advantage will continue to increase. The analyst reiterates an Outperform rating on the shares.
BK BNY Mellon
$43.13

-0.02 (-0.05%)

06/18/19
DBAB
06/18/19
DOWNGRADE
Target $44
DBAB
Hold
BNY Mellon downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Brian Bedell downgraded Charles Schwab to Hold from Buy and lowered his price target for the shares to $44 from $50. The analyst is downgrading some interest rate sensitive stocks in the Brokers and Asset Managers space ahead of the Q2 reporting season.
07/08/19
MSCO
07/08/19
DOWNGRADE
MSCO
Underweight
BNY Mellon downgraded to Underweight from Overweight at Morgan Stanley
Morgan Stanley analyst Betsy Graseck double downgraded BNY Mellon to Underweight from Overweight.
07/08/19
MSCO
07/08/19
DOWNGRADE
MSCO
Underweight
Morgan Stanley cuts large cap banks view, double downgrades State Street, BNY
As previously reported, Morgan Stanley analyst Betsy Graseck double downgraded State Street (STT) and BNY Mellon (BK), each to Underweight from Overweight, and downgraded her industry view for large cap banks to In-Line from Attractive. The group is up 23% year-to-date, but the next 6-18 months look tougher as global GDP is slowing, inflation expectations are dimming and the Fed is expected to cut rates in 2019 and 2020, which will make it "much harder for bank stocks to deliver positive surprises in operating leverage," Graseck tells investors. While she is not double downgrading the group to Cautious, because credit remains strong, Graseck sees trust banks as most exposed to the yield curve ahead of what she foresees as "18 months of rate cuts," the analyst added. She lowered her price targets on a number of large cap banks and cut her target on State Street to $55 from $69 while dropping her target for BNY to $41 from $50.
07/08/19
07/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Sell from Neutral at Rosenblatt with analyst Jun Zhang citing his view that its fundamental will deteriorate over the next 6-12 months. 2. Verizon (VZ) downgraded to Neutral from Buy at Citi with analyst Michael Rollins saying rising long-term industry risks and the stock's current valuation premium are likely to limit returns over the next 12-months. 3. F5 Networks (FFIV) downgraded to Sell from Neutral at Goldman Sachs with analyst Rod Hall saying the company's earnings risks are increasing due to the weaker short-term spending environment and increasing competitive threat. 4. BNY Mellon (BK) and State Street (STT) were double downgraded to Underweight from Overweight at Morgan Stanley. 5. American Airlines (AAL) downgraded to Underperform from Neutral at Credit Suisse with analyst Jose Caiado citing labor and Boeing (BA) 737 Max risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
OMC Omnicom
$84.08

0.065 (0.08%)

04/17/19
LEHM
04/17/19
UPGRADE
Target $84
LEHM
Equal Weight
Omnicom upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Julien Roch upgraded Omnicom to Equal Weight from Underweight and raised his price target for the shares to $84 from $76.
04/17/19
BMOC
04/17/19
NO CHANGE
Target $88
BMOC
Outperform
Omnicom price target raised to $88 from $85 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Omnicom to $88 and kept his Outperform rating after its management signaled that 2019 margins would improve by 20-30 bps over 2018, which followed the 60bps expansion in Q1. The analyst contends that the company had likely taken an "overly conservative initial view", noting that the margin change likely reflects an "elongated year-end process" thanks to "divestitures, management changes, and new account wins late in 2018."
04/17/19
04/17/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Neutral at JPMorgan and to Outperform from In Line at Evercore ISI. 2. Domino's Pizza (DPZ) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst John Glass saying he thinks the stock's current price reflects 2-3% blended global same store sales growth over the next two years, which he views as too bearish based on its track record as a "best in class operator." 3. TSYS (TSS) upgraded to Buy from Neutral at Goldman Sachs with analyst James Schneider saying the company's new portfolios are driving revenue growth while improving margin expansion is driving earnings acceleration. 4. Omnicom (OMC) upgraded to Equal Weight from Underweight at Barclays. 5. Jones Lang LaSalle (JLL) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Jade Rahmani saying she sees an attractive entry point following the recent underperformance of the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/14/19
BMOC
07/14/19
DOWNGRADE
Target $86
BMOC
Market Perform
Omnicom downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Daniel Salmon downgraded Omnicom Group to Market Perform from Outperform and lowered his price target for the shares to $86 from $88. The stock closed Friday up $1.04 to $84.69. After rallying 15% year-to-date, the shares are fully valued, Salmon tells investors in a research note. The analyst says the downgrade is not on call on Wednesday's Q2 results, as he believes those "will be fine."
TXT Textron
$54.02

0.59 (1.10%)

04/01/19
04/01/19
INITIATION
Target $50

Neutral
Textron started with Neutral at Credit Suisse on strong positions, mixed markets
As previously reported, Credit Suisse analyst Robert Spingarn initiated coverage of Textron with a Neutral rating and a $50 price target. The analyst notes that Textron is a market leader in many of its markets, including executive aviation, commercial rotorcraft, and specialized vehicles. However, many of these markets have low visibility and/or soft growth, which often require competitive pricing as well as continual product investment, he contended.
04/01/19
FBCO
04/01/19
INITIATION
FBCO
Neutral
Textron initiated with a Neutral at Credit Suisse
01/10/19
SUSQ
01/10/19
INITIATION
Target $52
SUSQ
Neutral
Textron initiated with a Neutral at Susquehanna
Susquehanna analyst Charles Minervino initiated Textron with a Neutral rating as its largest business, Textron Aviation, is in the midst of what will likely be a multi-year upcycle in business jet orders. Coupled with new product launches, the cycle should be an attractive tailwind for orders revenue growth and margin expansion. However, he believes the potential large-scale orders in Aviation and Bell are at least partially factored in already and notes that his 2019-2020 EPS estimates are slightly below consensus. Minervino has a $52 price target on Textron shares.
01/08/19
JEFF
01/08/19
NO CHANGE
Target $59
JEFF
Buy
Textron removed from Franchise Pick list at Jefferies
Jefferies analyst Sheila Kahyaoglu removed Textron from her firm's Franchise Pick list and lowered her price target for the shares to $59 from $68. The analyst continues to like Textron's potential to capture market share, but she believes consensus forecasts are likely too high for 2019. Kahyaoglu keeps a Buy rating on Textron.
CMA Comerica
$71.75

0.39 (0.55%)

07/12/19
SBSH
07/12/19
NO CHANGE
SBSH
Morgan Stanley upgrade, Wells downgrade among Citi's bank changes
Citi analyst Keith Horowitz made seven rating changes in the U.S. Banks space after updating his estimates and target prices for a new base case rate forecast that more closely reflects the forward curve. This includes two interest rate cuts in 2019 and 2020. The analyst's terminal yield curve assumptions to Fed Funds is 1.75%. The lower rate assumptions led him to lower his normal return on tangible equity estimates ~100 basis points on average. Following these changes, Horowitz upgraded Morgan Stanley (MS) to Buy from Neutral), downgraded Comerica (CMA), Northern Trust (NTRS), and M&T Bank (MTB) to Sell from Neutral, and downgraded Wells Fargo (WFC), Citizens Financial (CFG), and Fifth Third (FITB) to Neutral from Buy.
07/12/19
SBSH
07/12/19
DOWNGRADE
SBSH
Sell
Comerica downgraded to Sell from Neutral at Citi
Citi analyst Keith Horowitz downgraded Comerica to Sell from Neutral.
07/11/19
BOFA
07/11/19
DOWNGRADE
BOFA
Underperform
BofA double downgrades Comerica to Underperform, cuts Regions to Neutral
BofA Merrill Lynch analyst Erika Najarian downgraded Comerica two notches, to Underperform from Buy, citing the cloudier visibility on forward EPS given the more challenging backdrop. However, she noted that this rating change was not a call on the quarter but more about the environment for banks moving forward. Najarian also downgraded Regions Financial (RF) to Neutral from Buy, citing similar concerns.
07/11/19
BOFA
07/11/19
DOWNGRADE
BOFA
Underperform
Comerica downgraded to Underperform from Buy at BofA/Merrill

TODAY'S FREE FLY STORIES

NOVA

Sunnova Energy

$11.13

0.089 (0.81%)

21:22
08/19/19
08/19
21:22
08/19/19
21:22
Initiation
Sunnova Energy initiated at KeyBanc »

Sunnova Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SPY

SPDR S&P 500 ETF Trust

$292.31

3.52 (1.22%)

, SPX

S&P 500

$0.00

(0.00%)

20:54
08/19/19
08/19
20:54
08/19/19
20:54
Periodicals
Trump administration considering steps on economy if conditions worsen, NYT says »

White House officials…

SPY

SPDR S&P 500 ETF Trust

$292.31

3.52 (1.22%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$48.20

2.69 (5.91%)

, TJX

TJX

$51.55

0.13 (0.25%)

20:25
08/19/19
08/19
20:25
08/19/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KSS

Kohl's

$48.20

2.69 (5.91%)

TJX

TJX

$51.55

0.13 (0.25%)

MDT

Medtronic

$104.15

1.42 (1.38%)

HD

Home Depot

$207.98

4.335 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

BHP

BHP Group

$49.12

0.31 (0.64%)

19:32
08/19/19
08/19
19:32
08/19/19
19:32
Hot Stocks
BHP Group sees China and global economic growth slowing »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

BHP

BHP Group

$49.12

0.31 (0.64%)

19:25
08/19/19
08/19
19:25
08/19/19
19:25
Earnings
BHP Group reports FY19 Net profit up 124% at $8.31B »

Reports FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

AAPL

Apple

$210.32

3.88 (1.88%)

19:09
08/19/19
08/19
19:09
08/19/19
19:09
Periodicals
Apple aims for November launch of Apple+, Bloomberg reports »

Apple is targeting a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$195.19

2.005 (1.04%)

19:04
08/19/19
08/19
19:04
08/19/19
19:04
Hot Stocks
Accenture acquires Parker Fitzgerald, terms not disclosed »

Accenture has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Oct

BIDU

Baidu

$104.28

7.63 (7.89%)

, NBRV

Nabriva Therapeutics

$2.21

-0.06 (-2.64%)

18:47
08/19/19
08/19
18:47
08/19/19
18:47
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Baidu…

BIDU

Baidu

$104.28

7.63 (7.89%)

NBRV

Nabriva Therapeutics

$2.21

-0.06 (-2.64%)

MRNA

Moderna

$13.41

0.235 (1.78%)

VSLR

Vivint Solar

$8.30

0.3 (3.75%)

FN

Fabrinet

$56.40

0.77 (1.38%)

IQ

iQIYI

$18.10

1.02 (5.97%)

MRUS

Merus

$18.46

1.75 (10.47%)

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 19

    Aug

  • 19

    Aug

  • 19

    Aug

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 04

    Sep

  • 09

    Sep

  • 12

    Sep

ET

Energy Transfer LP

$13.77

0.3 (2.23%)

18:40
08/19/19
08/19
18:40
08/19/19
18:40
Periodicals
Energy Transfer LP performing maintenance on WTG pipeline, Reuters says »

A spokeswoman for Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$210.32

3.88 (1.88%)

, SNE

Sony

$55.71

-0.01 (-0.02%)

18:20
08/19/19
08/19
18:20
08/19/19
18:20
Periodicals
Apple allocates over $6B for original TV shows and movies, FT says »

Apple (AAPL) has budgeted…

AAPL

Apple

$210.32

3.88 (1.88%)

SNE

Sony

$55.71

-0.01 (-0.02%)

NFLX

Netflix

$309.40

6.66 (2.20%)

DIS

Disney

$135.33

0.14 (0.10%)

T

AT&T

$35.40

0.42 (1.20%)

CBS

CBS

$44.21

0.38 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 05

    Sep

  • 23

    Sep

  • 23

    Oct

LGIH

LGI Homes

$78.56

3.36 (4.47%)

18:01
08/19/19
08/19
18:01
08/19/19
18:01
Hot Stocks
LGI Homes opens two new communities in greater Seattle market »

LGI Homes announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,816.29

24.47 (1.37%)

18:01
08/19/19
08/19
18:01
08/19/19
18:01
Hot Stocks
Amazon.com to expand in Utah with new new fulfillment center »

Amazon.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

WMT

Walmart

$113.76

0.77 (0.68%)

18:00
08/19/19
08/19
18:00
08/19/19
18:00
Hot Stocks
Walmart to pay $100,000 to settle EEOC disability discrimination suit »

Wal-Mart Stores East, LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

X

U.S. Steel

$12.42

1.13 (10.01%)

17:58
08/19/19
08/19
17:58
08/19/19
17:58
Periodicals
U.S. Steel to lay off hundreds of workers at Great Lakes plant, Reuters says »

U.S. Steel plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

17:53
08/19/19
08/19
17:53
08/19/19
17:53
Hot Stocks
Breaking Hot Stocks news story on Sarepta »

Sarepta falls over 4% or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

17:52
08/19/19
08/19
17:52
08/19/19
17:52
Hot Stocks
FDA's CRL to Sarepta's golodirsen citing risk of infection, renal toxicity »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

BSX

Boston Scientific

$42.74

0.59 (1.40%)

17:41
08/19/19
08/19
17:41
08/19/19
17:41
Hot Stocks
Boston Scientific's ImageReady MRI labeling receives FDA approval »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

  • 13

    Nov

AMZN

Amazon.com

$1,816.29

24.47 (1.37%)

, GOOG

Alphabet

$1,198.01

21.07 (1.79%)

17:35
08/19/19
08/19
17:35
08/19/19
17:35
Periodicals
State AGs to proceed with antitrust investigation of big tech, WSJ reports »

A group of state…

AMZN

Amazon.com

$1,816.29

24.47 (1.37%)

GOOG

Alphabet

$1,198.01

21.07 (1.79%)

GOOGL

Alphabet Class A

$1,199.94

21.25 (1.80%)

FB

Facebook

$186.22

2.8 (1.53%)

MSFT

Microsoft

$138.43

2.3 (1.69%)

AAPL

Apple

$210.32

3.88 (1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

FB

Facebook

$186.22

2.8 (1.53%)

17:31
08/19/19
08/19
17:31
08/19/19
17:31
Periodicals
FTC head says breaking up Facebook could be complicated, FT reports »

Federal Trade Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

MPW

Medical Properties Trust

$18.28

0.13 (0.72%)

17:28
08/19/19
08/19
17:28
08/19/19
17:28
Hot Stocks
Medical Properties Trust COO sells 100K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

WMT

Walmart

$113.76

0.77 (0.68%)

17:17
08/19/19
08/19
17:17
08/19/19
17:17
Periodicals
Walmart's U.S. Chief Marketing Officer Barbara Messing is leaving, AdAge says »

Walmart U.S. Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

MAXR

Maxar Technologies

$6.49

0.185 (2.93%)

17:12
08/19/19
08/19
17:12
08/19/19
17:12
Hot Stocks
Maxar Technologies' MDA awarded Canadian Space Agency contract »

MDA, a Maxar company, has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCI

Rogers Communications

$51.30

0.21 (0.41%)

17:06
08/19/19
08/19
17:06
08/19/19
17:06
Hot Stocks
Rogers 'disappointed' by CRTC decision on broadband wholesale rates »

Rogers Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$18.10

1.02 (5.97%)

17:05
08/19/19
08/19
17:05
08/19/19
17:05
Hot Stocks
Breaking Hot Stocks news story on iQIYI »

iQIYI down over 6% or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

IQ

iQIYI

$18.10

1.02 (5.97%)

17:03
08/19/19
08/19
17:03
08/19/19
17:03
Hot Stocks
iQIYI reports Q2 total subscribing members 100.5M, up 50% from last year »

iQIYI's number of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.